Priority Date: 27.05.16 (US 201615167219)

A COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER

  • Application ID: EP17803189
  • Status: Request for examination was made

Attorney

operating since 1884
Headquarter in Birmingham and 7 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Forresters IP LLP is specialized in C12. Forresters IP LLP is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.05.2016 - Priority Date (US 201615167219)
  • 30.11.2017 - Publication A1 (WO2017204874)
  • 10.04.2019 - Publication A1 (EP3464591)